Search

You searched for: Author Soffer, Gissette Start Over

1. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Soffer, Gissette; Ginsberg, Henry N.; Berglund, Lars; Duell, P. Barton; Heffron, Sean P.; Kamstrup, Pia R.; Lloyd-Jones, Donald M.; Marcovina, Santica M.; Yeang, Calvin; Koschinsky, Marlys L.; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Peripheral Vascular Disease
2021
Articles
LipoproteinsAtherosclerosisCardiovascular systemCardiovascular system--Diseases--Risk factorsAmerican Heart Association

2. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.

Soffer, Gissette; Sztalryd, Carol; Horenstein, Richard B.; Holleran, Stephen F.; Matveyenko, Anastasiya; Thomas, Tiffany; Nandakumar, Renu; Ngai, Colleen I.; Karmally, Wahida; Ginsberg, Henry N.; Ramakrishnan, Rajasekhar; Pollin, Toni I.
2019
Articles
Cardiovascular system--DiseasesCardiovascular system--Diseases--Risk factorsApolipoproteinsBlood lipidsBlood lipoproteins--MetabolismMedicine

3. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

Tsimikas, Sotirios; Fazio, Sergio; Ferdinand, Keith C.; Ginsberg, Henry N.; Koschinsky, Marlys L.; Marcovina, Santica M.; Moriarty, Patrick M.; Rader, Daniel J.; Remaley, Alan T.; Soffer, Gissette; Santos, Raul D.; Thanassoulis, George; Witztum, Joseph L.; Danthi, Simhan; Olive, Michelle; Liu, Lijuan
2018
Articles
Cardiovascular system--Diseases--Risk factorsCardiovascular system--Diseases--ResearchAortic valve--StenosisLipoprotein AMedicine

4. CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects

Thomas, Tiffany; Zhou, Haihong; Karmally, Wahida; Ramakrishnan, Rajasekhar; Holleran, Stephen F.; Liu, Yang; Jumes, Patricia; Wagner, John A.; Hubbard, Brian; Previs, Stephen F.; Roddy, Thomas; Johnson-Levonas, Amy O.; Gutstein, David E.; Marcovina, Santica M.; Rader, Daniel J.; Ginsberg, Henry N.; Millar, John S.; Soffer, Gissette
2017
Articles
Lipoproteins--MetabolismBlood lipoproteinsHypercholesteremia--TreatmentLipoprotein AMedicine

5. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans

Soffer, Gissette; Pavlyha, Marianna; Ngai, Colleen I.; Thomas, Tiffany; Holleran, Stephen F.; Ramakrishnan, Rajasekhar; Karmally, Wahida; Nandakumar, Renu; Fontanez, Nelson; Obunike, Joseph; Marcovina, Santica M.; Lichtenstein, Alice H.; Matthan, Nirupa R.; Matta, James; Maroccia, Magali; Becue, Frederic; Poitiers, Franck; Swanson, Brian; Cowan, Lisa; Sasiela, William J.; Surks, Howard K.; Ginsberg, Henry N.
2017
Articles
Lipoproteins--MetabolismProprotein convertasesLipoprotein AMonoclonal antibodiesMedicine

7. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans

Soffer, Gissette; Moon, Byoung C.; Hernandez-Ono, Antonio; Dionizovik-Dimanovski, Marija; Jimenez, Jhonsua; Obunike, Joseph; Thomas, Tiffany; Karmally, Wahida; Ngai, Colleen I.; Donovan Jr, Daniel S.; Fontanez, Nelson; Ramakrishnan, Rajasekhar; Holleran, Stephen F.; Mittleman, Robert S.; Ginsberg, Henry N.
2016
Articles
Low density lipoproteinsApolipoproteinsBiosynthesisMedicine